Stada Names Novartis Exec as New CEO, It's Fifth Leader Since 2016 Post author:Sam Post published:January 31, 2018 Post category:BioPharma Today STADA announced the appointment of Peter Goldschmidt as new CEO and chairman of the board. Source: BioSpace You Might Also Like Tax Reform: A War on Life Sciences Innovation December 11, 2017 Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017 <b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017
Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017
<b>Provention Bio</b> Secures $28.4 Million Founding Financing To Fund Development Targeting The Interception And Prevention Of Immune-Mediated Disease June 25, 2017